ArticleBMC genomics2025
Gene fusion detection in long-read transcriptome sequencing data with GFvoter.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Review
- Review
- Systematic evaluation of long- and short-read RNA-seq for human peripheral blood.NAR molecular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Gene fusion is a prevalent occurrence in cancer patients, and fusions are significant both as diagnostic biomarkers and as therapeutic targets for cancer. Long-read transcriptome sequencing technology provides new opportunities for gene fusion detection. In this research, we have developed GFvoter, a novel method that employs a multivoting strategy to identify gene fusions from long-read transcriptome sequencing data. GFvoter calls two RNA-seq aligners, two fusion detection tools, and a newly designed scoring mechanism to conduct the so-called voting process in turn, which enables the accurate detection of potential fusions. We validated GFvoter using both simulated and real cell line datasets from PacBio and Nanopore and found that GFvoter significantly outperforms alternative methods. Moreover, GFvoter successfully reported the RPS6KB1:VMP1 gene fusion in the MCF-7 cell line, while none of the other tested tools detected this fusion. Overall, our findings show that GFvoter can accurately identify gene fusions from long-read RNA-seq data, which has the potential to improve cancer diagnosis and treatment. GFvoter is available at https://github.com/xiaolan-z/GFvoter .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.